Selenoprotein P Archives - Page 3 of 3

In cases of severe Covid-19 disease, patients have significantly lower concentrations of selenium and selenoprotein P and significantly higher levels of oxidative stress. That is to say, there is a more intense formation of harmful free radicals in patients with severe Covid-19 disease [Skesters 2022].

Corona virus — An adequate supply of selenium and zinc and vitamin D is essential for resistance to the corona viruses and to other viral infections. Here, Skesters er al show that Covid-19 patients have significantly lower levels of plasma selenium and selenoprotein P and significantly higher levels of oxidative stress.

Note: Oxidative stress is the bio-medical term for an imbalance between harmful free radical activity and protective antioxidant activity. Selenium is a key component of antioxidant selenoproteins such as the glutathione peroxidases and the thioredoxin reductases.

Role of Selenium and Selenoprotein P in Covid-19 Disease

Researchers have been investigating the role that selenium may play in reducing the severity and mortality of Covid-19 infections. Studies have shown a close relationship between low selenium status, Selenoprotein P deficiency, oxidative stress level, and Covid-19 disease incidence, severity, and prognosis [Skesters 2022]. read more

Research conclusion: “The 20% with lowest SELENOP concentrations in a N orth European population without history of cardiovascular disease have markedly increased risk of cardiovascular morbidity and mortality” [Schomburg 2019].

Heart attack — Selenoprotein-P deficiency predicts cardiovascular disease and death. Low selenium intakes result in sub-optimal bio-synthesis of selenoprotein P in the liver. Now, research shows that low selenoprotein P concentrations are associated with increased risk of cardiovascular disease and mortality.

This is the conclusion from the Malmö Preventive Project, a population-based prospective cohort study in southern Sweden, that examined the relationship between plasma selenoprotein P status and 1) risk of all-cause mortality, 2) risk of cardiovascular mortality, and 3) risk of a first cardiovascular event in 4366 study participants.

Note that this was a study done with study participants who had no history of cardiovascular disease. It was truly a study of the relationship between selenium status and the risk of heart disease. read more

Milestones in early selenium research

1817 Swedish chemist Jöns Jakob Berzelius discovers selenium

1957 Biochemist Klaus Schwarz shows that selenium in microscopic amounts has a vital importance for mammalian health

1969 Professor J.T. Rotruck discovers that selenium has a biochemical role as a component of the antioxidant enzyme glutathione peroxidase

1969 Professors R.J. Shamberger and D.V. Frost report a possible protective effect of selenium against cancer in humans

1973 Professor J.T. Rotruck identifies the enzyme glutathione peroxidase as a selenium-dependent protein

1977 Professor G.N. Schrauzer publishes cancer mortality correlation studies showing an inverse correlation between dietary intakes of selenium and cancer mortality in 27 countries

1988 Professor G.Q Yang summarizes the lessons learned about the selenium-related endemic diseases Keshan disease and Kashin-Beck disease and about the importance of adequate daily selenium intakes

1989 Professor G.G. Duthie publishes evidence for a role of selenium in the prevention of cardiovascular disease

1993 Researcher W.J. Blot publishes the results of the Nutrition Intervention Trials in Linxian, China, showing that supplementation with a combination of selenium and other antioxidants reduces the risk of cancer

1994 Professor G.N. Schrauzer publishes evidence that selenium is important in the maintenance and therapy of HIV-infected patients

1996 Professor Larry Clark publishes the results of a randomized controlled trial – the Nutritional Prevention of Cancer study -- that shows selenium's cancer-protective effects on colon cancer, lung cancer, and prostate cancer

1997 Professor G.F. Combs summarizes the evidence for the protective effects of selenium against cancer

1999 Professor J.E. Oldfield publishes his Selenium World Atlas, mapping areas of selenium deficiency around the world

2000 Researcher O.A. Levander publishes evidence showing an anti-viral effect of selenium

2002 Researcher R. Gärtner shows that supplementation with selenium reduces inflammation in patients with autoimmune thyroiditis

2002 Researcher Margaret Rayman presents the arguments for increasing selenium intakes to realize selenium’s antioxidant and anti-viral and anti-inflammatory effects as well as selenium’s enhancement of immune function and reproductive success.

Tag: Selenoprotein P

Selenium Status and Covid-19 Patients

Role of Selenium and Selenoprotein P in Covid-19 Disease

Plasma Selenoprotein P Levels and the Risk of Cardiovascular Disease